Correlation Between Viracta Therapeutics and OnKure Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and OnKure Therapeutics,, you can compare the effects of market volatilities on Viracta Therapeutics and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and OnKure Therapeutics,.

Diversification Opportunities for Viracta Therapeutics and OnKure Therapeutics,

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Viracta and OnKure is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and OnKure Therapeutics, go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and OnKure Therapeutics,

Given the investment horizon of 90 days Viracta Therapeutics is expected to generate 1.14 times more return on investment than OnKure Therapeutics,. However, Viracta Therapeutics is 1.14 times more volatile than OnKure Therapeutics,. It trades about -0.02 of its potential returns per unit of risk. OnKure Therapeutics, is currently generating about -0.05 per unit of risk. If you would invest  76.00  in Viracta Therapeutics on October 6, 2024 and sell it today you would lose (54.00) from holding Viracta Therapeutics or give up 71.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viracta Therapeutics  vs.  OnKure Therapeutics,

 Performance 
       Timeline  
Viracta Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Viracta Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Viracta Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
OnKure Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Viracta Therapeutics and OnKure Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viracta Therapeutics and OnKure Therapeutics,

The main advantage of trading using opposite Viracta Therapeutics and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.
The idea behind Viracta Therapeutics and OnKure Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities